# Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome

> **NCT00666848** · PHASE4 · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 24 (actual)

## Conditions studied

- Metabolic Syndrome
- Hypertension

## Interventions

- **DRUG:** Placebo
- **DRUG:** Enalapril 5mg
- **DRUG:** Enalapril 10mg
- **DRUG:** Sitagliptin

## Key facts

- **NCT ID:** NCT00666848
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-08
- **Final completion:** 2010-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00666848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00666848, "Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00666848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*